Phyton Biotech is the world’s first and only company to harness plant cell fermentation (PCF®) technology for development and commercialization of plant-derived pharmaceuticals. Phyton’s scalable and environmentally responsible PCF® platform has resulted in high-value commercial oncology actives and scalable expression systems for complex plant-based molecules for pharmaceutical development.
Phyton Biotech is the world’s largest commercial provider of high quality Paclitaxel and Docetaxel API via PCF®
and we proudly call many of the world’s leading injectables companies our customers.
With GMP facilities near Hamburg and Vancouver, Phyton also provides a broad range of
development services for plant-based actives and other complex molecules.